EyePoint (EYPT) Enterprise Value Growth (3y) (2013 - 2026)
EyePoint (EYPT) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.03% |
| Dec 31, 2025 | -28.41% |
| Sep 30, 2025 | -9.07% |
| Jun 30, 2025 | -14.32% |
| Mar 31, 2025 | -18.59% |
| Dec 31, 2024 | -20.58% |
| Sep 30, 2024 | -28.46% |
| Jun 30, 2024 | -29.99% |
| Mar 31, 2024 | -29.27% |
| Dec 31, 2023 | -94.62% |
| Sep 30, 2023 | -67.92% |
| Jun 30, 2023 | -84.16% |
| Mar 31, 2023 | -66.99% |
| Dec 31, 2022 | -86.70% |
| Sep 30, 2022 | -70.44% |
| Jun 30, 2022 | -57.08% |
| Mar 31, 2022 | -63.84% |
| Dec 31, 2021 | -67.20% |
| Sep 30, 2021 | -29.00% |
| Jun 30, 2021 | -48.74% |